Fondaparinux indications: Difference between revisions

Latest revision as of 16:20, 21 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-Fondaparinux sodium (Arixtra) Injection is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism:
+#REDIRECT [[Fondaparinux#Adult Indications and Dosage]]
-* in patients undergoing hip fracture surgery, including extended prophylaxis;
+[[Category: Cardiovascular Drugs]]
-* in patients undergoing hip replacement surgery;
+[[Category: Drug]]
-* in patients undergoing knee replacement surgery;
+[[Category: Anticoagulants]]
-* in patients undergoing abdominal surgery who are at risk for thromboembolic complications.
-Fondaparinux sodium (Arixtra) Injection is indicated for:
-* the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium, and
-* the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital.